CONVERTIBLE BONDS (Details Narrative) - Convertible Bonds [Member] - Maius Pharmaceutical Co. Ltd [Member] - USD ($) |
6 Months Ended | ||
|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Nov. 22, 2024 |
|
| Short-Term Debt [Line Items] | |||
| Debt Instrument, Face Amount | $ 300,000 | ||
| Debt Instrument, Interest Rate, Stated Percentage | 8.00% | ||
| Share Price | $ 10.00 | ||
| Interest expenses | $ 8,546 | ||
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|